about
The weight of obesity on the human immune response to vaccinationChemical Modification of Influenza CD8+ T-Cell Epitopes Enhances Their Immunogenicity Regardless of ImmunodominanceAdvances in influenza vaccination.An Intranasal Virus-Like Particle Vaccine Broadly Protects Mice from Multiple Subtypes of Influenza A Virus.Immunogenicity of Virus Like Particle Forming Baculoviral DNA Vaccine against Pandemic Influenza H1N1.Virus-vectored influenza virus vaccines.Influenza vaccines: challenges and solutions.Coupling high-throughput genetics with phylogenetic information reveals an epistatic interaction on the influenza A virus M segment.In Silico Identification of Highly Conserved Epitopes of Influenza A H1N1, H2N2, H3N2, and H5N1 with Diagnostic and Vaccination PotentialMethylglycol chitosan and a synthetic TLR4 agonist enhance immune responses to influenza vaccine administered sublingually.Effective Respiratory CD8 T-Cell Immunity to Influenza Virus Induced by Intranasal Carbomer-Lecithin-Adjuvanted Non-replicating Vaccines.Universal Influenza Vaccines: To Dream the Possible Dream?Vaccination against infectious diseases: what is promising?Functional nanomaterials can optimize the efficacy of vaccines.Mucosal immunization with a flagellin-adjuvanted Hgp44 vaccine enhances protective immune responses in a murine Porphyromonas gingivalis infection model.Role of vitamin D in cytotoxic T lymphocyte immunity to pathogens and cancer.From Variation of Influenza Viral Proteins to Vaccine Development.Roles of antibodies to influenza A virus hemagglutinin, neuraminidase, and M2e in conferring cross protection.In Silico Analysis of HA2/Mx Chimera Peptide for Developing an Adjuvanted Vaccine to Induce Immune Responses Against Influenza Viruses.Advances in Vaccines to Prevent Viral Respiratory Illnesses in Children.Roads to advanced vaccines: influenza case study.The significance of avian influenza virus mouse-adaptation and its application in characterizing the efficacy of new vaccines and therapeutic agents.Anti-Infectious Human Vaccination in Historical Perspective.Immune responses to highly conserved influenza A virus matrix 1 peptides.Porcine epidemic diarrhea virus virus-like particles produced in insect cells induce specific immune responses in mice.Immunogenicity and sustainability of the immune response in Brazilian HIV-1-infected individuals vaccinated with inactivated triple influenza vaccine.Induction of a robust immune response against avian influenza virus following transdermal inoculation with H5-DNA vaccine formulated in modified dendrimer-based delivery system in mouse model.Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs
P2860
Q28088540-E361F950-6778-4177-AA54-AD76A5F0DF10Q28552025-E501E0D8-8D6F-4308-91AC-9E95ADDA19BAQ30364315-D3C9656D-D123-4F88-8BAB-BD5481C66062Q30377023-D6670094-76BE-4703-9B4F-53DA09A232EFQ30387699-02D229F4-E923-496C-B55B-F7A450E2FA46Q34102268-61CCB28F-A32A-4212-B124-83E5393A0CB8Q35184572-CA8E183E-0166-414E-992D-F165A27CB18FQ35891196-BFFB7F2E-574B-4CFE-A5D7-B4199F96A70CQ35982621-164353A3-F720-475B-A5D7-C6F2745E477BQ36173746-22A14D1C-AC2E-410C-8EE7-9D4A4F89A09DQ36229655-91C7F40D-4B93-4528-820D-C41C9DF49302Q36675360-021F20D7-62BB-4F88-B331-4AB795FAA6C3Q38234231-B93419E4-C481-448F-BD76-6E98836CE239Q38252639-B55C2A4E-05B5-4472-8C72-3EA9F00DDE6FQ38401993-1714A14A-0B58-4BAD-98EB-F8B3D3A8955BQ38610901-03EDA610-CC9D-4A80-AD86-32643EB1A352Q39441534-D77102D0-01D7-4BFF-84D9-4FE7A5D19C88Q40050261-55A2361E-C8D6-407F-B0B2-20C017DF454DQ40079652-3926EF16-70E0-4A29-BA7E-A8A940DBD805Q40082914-C120C164-EE58-4FB1-B375-2DFEA8AA100AQ40092863-29363E53-D194-42A4-A7BD-3FE279BC6FD8Q40095150-27D8C91D-A29D-4A4B-BA57-A59031D316FAQ40129444-30EFD01B-7BAB-4036-8208-B26059B7EB31Q40233388-08B93CA9-A536-4EC1-AC58-2472BB7BBBA6Q40267316-457EC9E5-3D7B-47CA-92FF-BEB2DEB9FDDFQ41056130-E9200763-C9BA-471F-875F-3AC7D42B0681Q47136368-D36E9E13-EB13-4F35-92D3-93D5BB00C180Q47442073-D8E27CAA-06FA-40D8-AB00-90B4CAB44614Q58698634-F07F9E43-5D90-4C41-8208-19721C3726E3
P2860
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
New vaccines against influenza virus.
@ast
New vaccines against influenza virus.
@en
type
label
New vaccines against influenza virus.
@ast
New vaccines against influenza virus.
@en
prefLabel
New vaccines against influenza virus.
@ast
New vaccines against influenza virus.
@en
P2093
P2860
P356
P1476
New vaccines against influenza virus.
@en
P2093
Ki-Hye Kim
Min-Chul Kim
Min-Kyoung Cho
Sang-Moo Kang
Yinghua Tang
Youn-Jeong Lee
Young-Man Kwon
Young-Tae Lee
P2860
P356
10.7774/CEVR.2014.3.1.12
P577
2013-12-18T00:00:00Z